| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 58 |
| 1 | PREDNISOLONE | 49 |
| 2 | PREDNISOLONE ORAL | 49 |
| 3 | PREDNISOLONE ORAL SOLUTION | 49 |
| 4 | METHOTREXATE SODIUM | 42 |
| 5 | METHOTREXATE | 41 |
| 6 | AZATHIOPRINE | 33 |
| 7 | DEXAMETHASONE | 33 |
| 8 | DEXAMETHASONE 1.5 MG | 33 |
| 9 | PREDNISONE | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IBERDOMIDE | 1 | 0.0067 |
| 1 | CHLORAMBUCIL | 8 | 0.0020 |
| 2 | ALEMTUZUMAB | 24 | 0.0012 |
| 3 | AMPICILLIN INJECTION | 9 | 0.0012 |
| 4 | AMPICILLIN AND SULBACTAM | 1 | 0.0011 |
| 5 | MIRIKIZUMAB-MRKZ | 1 | 0.0011 |
| 6 | AMPICILLIN | 9 | 0.0011 |
| 7 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 2 | 0.0011 |
| 8 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 2 | 0.0008 |
| 9 | BLEOMYCIN SULFATE | 6 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 123 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 81 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 40 |
| 3 | Purine Antimetabolite [EPC] | 34 |
| 4 | Alkylating Drug [EPC] | 30 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 24 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 24 |
| 7 | Proton Pump Inhibitor [EPC] | 21 |
| 8 | Thalidomide Analog [EPC] | 21 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 20 | 0.0034 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 24 | 0.0012 |
| 2 | Reducing and Complexing Thiol [EPC] | 1 | 0.0004 |
| 3 | Purine Antimetabolite [EPC] | 34 | 0.0003 |
| 4 | Calcitonin [EPC] | 1 | 0.0003 |
| 5 | Antimalarial [EPC] | 3 | 0.0003 |
| 6 | Antiprotozoal [EPC] | 3 | 0.0003 |
| 7 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 8 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 9 | Topoisomerase Inhibitor [EPC] | 17 | 0.0002 |